Submitted by Anonymous (not verified) on 28 July 2025 - 15:27
Human medicines European public assessment report (EPAR): Hukyndra, adalimumab, Date of authorisation: 15/11/2021, Revision: 10, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Hukyndra, adalimumab, Date of authorisation: 15/11/2021, Revision: 10, Status: Authorised